Biopico Systems specializes in advanced microphysiological systems technology, particularly through its OrganRX™ platform, which is designed to create functional organ tissues for therapeutic applications. The OrganRX™ Tissue technology enables the construction of transplantable tissues that can be used for organ repair, leveraging biomimetic approaches to replicate the complexities of human organs. This system includes a multi-organ recirculation setup that facilitates passive, gravity-driven shear flow, allowing for the culture of various micro-organs such as the liver, kidney, gut, and brain. The OrganRX™ Plate, a disposable injection-molded glass bottom plate, supports the growth of primary cells, cell lines, or induced pluripotent stem (iPS) cells, enabling researchers to study organ interactions and functions in a controlled environment.

The applications of the OrganRX™ technology are extensive, addressing critical areas in drug discovery and disease modeling. It allows for the testing of compounds in both 2-D and 3-D models, including blood-brain barrier simulations, which are essential for understanding the transport characteristics of drugs to and from the brain. The platform supports various research applications, including studies on cancer metastasis, inflammation, microbiome interactions, and vascular development. By accurately recapitulating human physiology, Biopico Systems aims to enhance preclinical drug development and provide more predictive models for precision medicine, ultimately contributing to advancements in regenerative medicine and therapeutic discoveries.

United States

Biopico Systems Inc is a leader in the emerging field of interacting multiple organ systems or microphysiological systems technology. This technology will accurately recapitulate human physiology by engineering physiological fluidic flow and organ microenvironment.

Biopico Systems

Company Details